Cargando…

Changes of natural killer cells’ phenotype in patients with chronic hepatitis B in intermittent interferon therapy

BACKGROUND: To investigate the changes of natural killer (NK) cell phenotype in the interferon alpha (IFN-α) treatment of chronic hepatitis B (CHB) and its relationship with clinical indicators. METHODS: The CHB patients who did not receive any antiviral treatment were set as initial treatment group...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Xiaoyue, Xie, Si, Wu, Shuling, Cao, Weihua, Lin, Yanjie, Yang, Liu, Jiang, Tingting, Deng, Wen, Wang, Shiyu, Liu, Ruyu, Gao, Yuanjiao, Shen, Ge, Chang, Min, Hao, Hongxiao, Xu, Mengjiao, Chen, Xiaoxue, Hu, Leiping, Lu, Yao, Zhang, Lu, Xie, Yao, Li, Minghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922744/ https://www.ncbi.nlm.nih.gov/pubmed/36793722 http://dx.doi.org/10.3389/fimmu.2023.1116689

Ejemplares similares

Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy
por: Cao, Weihua, et al.
Publicado: (2022)

The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy
por: Cao, Weihua, et al.
Publicado: (2021)

Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B
por: Xie, Si, et al.
Publicado: (2022)

Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment
por: Lin, Yanjie, et al.
Publicado: (2023)

A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L
por: Zhang, Lu, et al.
Publicado: (2023)

Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection
por: Zhang, Lu, et al.
Publicado: (2023)

Study on liver histopathology of chronic HBV infected patients with different normal ALT values
por: Zeng, Zhan, et al.
Publicado: (2022)

Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy
por: Liu, Ruyu, et al.
Publicado: (2023)

Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection
por: Sun, Fangfang, et al.
Publicado: (2022)

Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity
por: Lu, Huihui, et al.
Publicado: (2023)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
por: Zeng, Zhan, et al.
Publicado: (2023)

The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection
por: Wang, Fuchuan, et al.
Publicado: (2022)

Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B
por: Li, Minghui, et al.
Publicado: (2022)

Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection
por: Wu, Shuling, et al.
Publicado: (2022)

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients
por: Li, Minghui, et al.
Publicado: (2022)

Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment
por: Cao, Weihua, et al.
Publicado: (2022)

Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT
por: Zhang, Lu, et al.
Publicado: (2023)

Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients
por: Li, Minghui, et al.
Publicado: (2022)

Effect of Antiviral Therapy During Pregnancy on Natural Killer Cells in Pregnant Women With Chronic HBV Infection
por: Wang, Fuchuan, et al.
Publicado: (2022)

Advances in Metagenomics and Its Application in Environmental Microorganisms
por: Zhang, Lu, et al.
Publicado: (2021)

The reduction in CD8(+)PD-1(+) T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients
por: Liu, Ruyu, et al.
Publicado: (2020)

Severe coagulopathy caused by cefminox sodium in a liver cirrhosis patient: a case report
por: Wu, Shuling, et al.
Publicado: (2022)

Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma
por: Xu, Mengjiao, et al.
Publicado: (2022)

Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients
por: Li, Minghui, et al.
Publicado: (2022)

Application of Lab-on-Chip for Detection of Microbial Nucleic Acid in Food and Environment
por: Yang, Liu, et al.
Publicado: (2021)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
por: Liu, Yan, et al.
Publicado: (2017)

Mode of regulation of natural killer cell activity by interferon
por: Minato, N, et al.
Publicado: (1980)

Editorial: Interferon and its antiviral effect in response to HBV infection
por: Song, Hongxiao, et al.
Publicado: (2023)

Type I Interferons and Natural Killer Cell Regulation in Cancer
por: Müller, Lena, et al.
Publicado: (2017)

Activation of natural killer cells in newborn piglets by interferon induction
por: Lesnick, C.E., et al.
Publicado: (1988)

Development of nutrition label use scale for patients of coronary heart disease and examination of its reliability and validity
por: Pan, Lu, et al.
Publicado: (2023)

When Hepatitis B Virus Meets Interferons
por: Tan, Guangyun, et al.
Publicado: (2018)

SRC-3 Knockout Attenuates Myocardial Injury Induced by Chronic Intermittent Hypoxia in Mice
por: Wang, Wanyu, et al.
Publicado: (2021)

Aspirin Inhibits Natural Killer/T-Cell Lymphoma by Modulation of VEGF Expression and Mitochondrial Function
por: Zhang, Hongyu, et al.
Publicado: (2019)

Two Novel Adenovirus Vectors Mediated Differential Antibody Responses via Interferon-α and Natural Killer Cells
por: Zou, Peng, et al.
Publicado: (2023)

Role of Uterine Natural Killer Cells and Interferon γ in Placental Development
por: Redline, Raymond W.
Publicado: (2000)

CD11c(lo)B220(+) interferon-producing killer dendritic cells are activated natural killer cells
por: Vosshenrich, Christian A.J., et al.
Publicado: (2007)

Reinforced Cytotoxicity of Lymphokine‐activated Killer Cells toward Glioma Cells by Transfection of the Killer Cells with the γ‐Interferon Gene
por: Mizuno, Masaaki, et al.
Publicado: (1995)

Autologous Enhancement by Interferon of Natural Killer Activity of Human Peripheral Blood Lymphocytes
por: Cheknev, S. B., et al.
Publicado: (1994)

Production of interferon-gamma by natural killer cells and aging in chronic human schistosomiasis.
por: Speziali, E, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_7a2r7koci7ma2oobb99a3et4jr